LogicBio Therapeutics Inc
NASDAQ:LOGC
Cash Flow Statement
Cash Flow Statement
LogicBio Therapeutics Inc
Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||
Net Income |
(8)
|
(10)
|
(14)
|
(18)
|
(23)
|
(29)
|
(36)
|
(40)
|
(42)
|
(40)
|
(37)
|
(33)
|
(33)
|
(36)
|
(38)
|
(40)
|
(36)
|
(31)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Other Non-Cash Items |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Change in Working Capital |
(1)
|
(1)
|
(1)
|
1
|
1
|
1
|
1
|
(2)
|
0
|
(2)
|
(1)
|
(2)
|
(2)
|
14
|
11
|
15
|
10
|
(3)
|
|
Cash from Operating Activities |
(9)
N/A
|
(11)
-20%
|
(13)
-25%
|
(15)
-14%
|
(20)
-33%
|
(26)
-27%
|
(32)
-22%
|
(39)
-22%
|
(38)
+2%
|
(38)
+1%
|
(33)
+12%
|
(29)
+13%
|
(29)
-2%
|
(17)
+44%
|
(21)
-28%
|
(19)
+11%
|
(21)
-10%
|
(28)
-36%
|
|
Investing Cash Flow | |||||||||||||||||||
Capital Expenditures |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Other Items |
0
|
0
|
0
|
0
|
(45)
|
(38)
|
(24)
|
(17)
|
45
|
38
|
25
|
18
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Investing Activities |
(0)
N/A
|
(0)
+25%
|
(0)
-1 000%
|
(1)
-76%
|
(45)
-7 726%
|
(39)
+14%
|
(25)
+35%
|
(19)
+27%
|
44
N/A
|
37
-15%
|
24
-36%
|
17
-29%
|
(1)
N/A
|
(1)
0%
|
(1)
-38%
|
(1)
+4%
|
(1)
+17%
|
(1)
+23%
|
|
Financing Cash Flow | |||||||||||||||||||
Net Issuance of Common Stock |
0
|
0
|
0
|
75
|
0
|
75
|
75
|
0
|
0
|
2
|
3
|
49
|
51
|
49
|
51
|
5
|
0
|
3
|
|
Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
10
|
10
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
|
Other |
(0)
|
0
|
(1)
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
29
N/A
|
0
N/A
|
(1)
N/A
|
72
N/A
|
72
N/A
|
72
+0%
|
83
+15%
|
10
-88%
|
10
+1%
|
12
+18%
|
3
-72%
|
49
+1 337%
|
51
+4%
|
49
-4%
|
49
+2%
|
3
-93%
|
0
-90%
|
(0)
N/A
|
|
Change in Cash | |||||||||||||||||||
Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Change in Cash |
20
N/A
|
(11)
N/A
|
(15)
-35%
|
56
N/A
|
7
-88%
|
7
+12%
|
26
+253%
|
(47)
N/A
|
16
N/A
|
12
-26%
|
(6)
N/A
|
37
N/A
|
21
-44%
|
31
+52%
|
27
-13%
|
(17)
N/A
|
(21)
-28%
|
(29)
-38%
|
|
Free Cash Flow | |||||||||||||||||||
Free Cash Flow |
(9)
N/A
|
(11)
-20%
|
(14)
-28%
|
(16)
-15%
|
(21)
-34%
|
(27)
-28%
|
(33)
-21%
|
(40)
-22%
|
(39)
+2%
|
(39)
+2%
|
(34)
+12%
|
(29)
+13%
|
(30)
-2%
|
(17)
+43%
|
(22)
-29%
|
(20)
+11%
|
(22)
-9%
|
(29)
-34%
|